VALID focuses on addressing this critical issue using advanced/complex hiPSC-derived models with increased predictive validity.
Valid Therapeutics has raised $6.9M in total funding. The most recent round was Undisclosed. The last funding was announced in January 2025.
Valid Therapeutics is headquartered in Natick, United States.
VALID focuses on addressing this critical issue using advanced/complex hiPSC-derived models with increased predictive validity.
Valid Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Valid Therapeutics — Funding & Investors." VCBacked, January 21, 2025, https://www.vcbacked.co/company/valid-therapeutics. Accessed August 17, 2026.
VCBacked. (2025). Valid Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/valid-therapeutics
{{cite web |title=Valid Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/valid-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated